DAY 3: Saturday, May 9th
SESSION 4: ESSENTIAL THROMBOCYTHAEMIA
Chairs: A. Álvarez-Larrán, R. Kušec
| 09:30 - 09:55 | Treatment of ET over the years | M. Griesshammer |
| 09:55 - 10:20 | Diagnosis in ET | H. M. Kvasnicka |
| 10:20 - 10:45 | Risk stratification in ET | A. Godfrey |
| Current trends in clinical trials in ET | ||
| 10:45 - 11:00 | Progression from ET to PV | T. Barbui |
| 11:00 – 11:15 | Role of neutrophils in the thrombosis of chronic myeloproliferative neoplasms: New therapeutic opportunities | F. Ferrer-Marín |
| 11:15 - 11:30 | Discussion | |
| 11:30 - 12:00 | Interferon in ET | A. Álvarez-Larrán |
| 12:00 - 12:15 | Concluding words | H. Gisslinger |